HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Classifying E-Cigarettes As Tobacco Snuffs Out Cessation Utility – FDA

This article was originally published in The Tan Sheet

Executive Summary

FDA makes a case for regulating electronic cigarettes as nicotine-replacement therapies, calling the products "a promising tool" in controlling tobacco use.

You may also be interested in...



In Brief

FDA works on e-cigarette regulations

In Brief

FDA encourages disclosures at public hearings

Smoking Cessation Claims For E-Cigarettes Draw FDA Warnings

FDA sets ground rules for regulating electronic cigarettes in warning letters to five firms about unapproved smoking cessation claims and in a separate summary letter to an industry trade group

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS134049

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel